Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes
Karly C. Sourris(Baker Heart and Diabetes Institute), Josephine M. Forbes(Translational Research Institute), Amy L. Morley(Baker Heart and Diabetes Institute), Melinda T. Coughlan(Baker Heart and Diabetes Institute), Mark E. Cooper(Baker Heart and Diabetes Institute), Brooke E. Harcourt(Albert Einstein College of Medicine), Tuong‐Vi Nguyen(Baker Heart and Diabetes Institute), Karina Huynh(Baker Heart and Diabetes Institute), Rebecca H. Ritchie(Baker Heart and Diabetes Institute), Sally A. Penfold(Albert Einstein College of Medicine), Peter Tang(University of Cincinnati)
Cited by 117
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Diabetic kidney disease
|Nature Reviews Disease Primers|2015|1.2k
Basic Mechanisms of Diabetic Heart Disease
|Circulation Research|2020|690
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
|Journal of the American Society of Nephrology|2009|461